FxPro Adds Medline Shares to Its Tradable Stock Line-up
FxPro now offers trading in Medline (MDLN.O), with positions available from 0.01 shares in either direction via MT5 or the FxPro App. The broker's notice carries its standard CFD warning that 74% of retail investor accounts lose money trading these products with FxPro.
View original sourceFxPro has added Medline (MDLN.O) to the stocks clients can trade, with a minimum size of 0.01 shares and the option to go long or short. Access is through MT5 or the FxPro App, and the broker frames the addition as part of making new listings available as they come to market. The notice presents the instrument within the broker's leveraged product range: it carries a warning that CFDs and spread betting are complex instruments with a high risk of rapid loss through leverage, and that 74% of retail investor accounts lose money trading them with FxPro. The announcement does not set out which FxPro entities or jurisdictions the instrument is offered to, and its references to execution speed and spreads are the broker's own description of its service.
FxPro News · The FxPro Analyst Team
Medline (MDLN.O) has made a powerful entrance into public markets, surging 41% on its Nasdaq debut following the largest IPO of 2025 so far. The strong first-day performance highlights renewed investor appetite for high-quality healthcare and industrial names, even amid broader market uncertainty.
A Landmark IPO
Medline officially began trading on Nasdaq after raising billions in a blockbuster listing that quickly became the standout IPO of the year. Demand was strong from both institutional and retail investors, driving shares sharply higher in early trading.
Why Medline Is a Stock to Watch
Founded more than 50 years ago, Medline is one of the world’s largest suppliers of medical and surgical products, serving hospitals, clinics, and healthcare providers across the globe. Its catalogue includes hundreds of thousands of medical supplies, ranging from basic consumables to advanced healthcare equipment.
In a market often dominated by technology IPOs, Medline’s debut stands out as a reminder that fundamentals still matter.
Trade Medline with FxPro
You can now trade Medline shares with FxPro and take advantage of post IPO volatility as the stock finds its footing in public markets.
With FxPro, you can:
- Trade Medline from 0.01 shares
- Go long or short depending on market direction
- Trade via MT5 or the FxPro App
- Benefit from fast execution and tight spreads
- Access new stocks, including major IPOs, as they become available
Medline’s strong debut makes it a stock worth watching as 2025’s IPO calendar gathers momentum.
Trade responsibly.CFDs and Spread Betting are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider. You should consider whether you understand how these products work and whether you can afford to take the high risk of losing your money.
Article information
This article draws on the cited sources and relevant public material. It may include summaries, translations or supporting analysis and does not replace the full announcement, regulatory document or dataset. Check facts, definitions, statistical methods and effective conditions against the original source, particularly where a translation differs.
Companies, broker brands and legal entities must be distinguished. A licence, permission or announcement concerning one entity should not automatically be applied to related brands, other entities, products or jurisdictions. Reporting and commentary do not constitute investment advice, trading recommendations or assurances of safety, compliance or suitability.
Information is time-sensitive: announcements, register entries and data may be updated or revised. The publication and update dates on this page refer to this website’s article record and may differ from the event or original release date. Before acting, check current source material, the applicable jurisdiction and your actual contracting entity.
Comments